GAITHERSBURG, Md., Feb. 27,
2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX),
today announced that the management team will participate in the
following upcoming investor conferences:
|
TD Cowen
45th Annual Health Care
Conference:
|
|
Fireside
Chat
|
|
Date:
|
Tuesday, March 4,
2025
|
|
|
Time:
|
9:10 – 9:40 a.m.
Eastern Time (ET)
|
|
|
Location:
|
Boston, MA
|
|
|
Conference
|
|
Event:
|
Investor
Meetings
|
|
|
Date:
|
Tuesday, March 4,
2025
|
|
|
|
Leerink Partners
2025 Global Healthcare Conference:
|
|
Presentation
|
|
Date:
|
Tuesday, March 11,
2025
|
|
|
Time:
|
3:40 – 4:10 p.m.
ET
|
|
|
Location:
|
Miami Beach,
FL
|
|
|
Conference
|
|
Event:
|
Investor
Meetings
|
|
|
Date:
|
Tuesday, March 11,
2025
|
|
|
|
|
|
Jefferies Biotech on
the Beach Summit:
|
|
Conference
|
|
Event:
|
Investor
Meetings
|
|
|
Date:
|
Wednesday, March 12,
2025
|
|
|
Location:
|
Miami Beach,
FL
|
A webcast of the fireside chat and presentation will be
available through the Events and Presentations page of the
Company's website at ir.novavax.com, with replays available for 30
days after the conferences.
About Novavax
Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most
significant health challenges by leveraging its scientific
expertise in vaccines and its cutting-edge technology platform,
including a protein-based nanoparticle and Matrix-M™ adjuvant. The
Company's growth strategy is focused on building new and
diversified partnerships via the out-licensing of its technology
platform and vaccine assets earlier in the development process.
These strategic collaborations are fueled by smart investments in a
growing early-stage pipeline starting with the Company's core
expertise in infectious disease and potentially expanding into
other disease areas. Please visit novavax.com and LinkedIn for more
information.
Contacts:
Investors
Luis Sanay, CFA
240-268-2022
ir@novavax.com
Media
Giovanna Chandler
202-709-5563
media@novavax.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-upcoming-march-investor-conferences-302387404.html
SOURCE Novavax, Inc.
